Literature DB >> 11676431

Prevalence, recognition, and treatment of comorbid depression and anxiety.

M H Rapaport1.   

Abstract

The management of depression is often complicated by comorbid psychiatric illness. Incomplete diagnoses or inadequate treatment can severely limit a patient's improvement. However, careful diagnosis and straightforward treatment can relieve suffering and restore function. This article will examine recent research investigating the coexistence of depression with a number of different anxiety disorders and review literature on the prevalence and recognition of depression with comorbid anxiety disorders. Finally, current data on treatment will be discussed, with a focus on optimal treatment approaches and duration of treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676431

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  10 in total

1.  Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice.

Authors:  B K Yee; S-W Zhu; A H Mohammed; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

2.  Decreased serum L-arginine and L-citrulline levels in major depression.

Authors:  S Hess; G Baker; G Gyenes; R Tsuyuki; S Newman; Jean-Michel Le Melledo
Journal:  Psychopharmacology (Berl)       Date:  2017-08-13       Impact factor: 4.530

3.  Antidepressant-like properties of α2-containing GABA(A) receptors.

Authors:  Isabel Vollenweider; Kiersten S Smith; Ruth Keist; Uwe Rudolph
Journal:  Behav Brain Res       Date:  2010-10-20       Impact factor: 3.332

4.  Anxiety and suicidality in the college student population.

Authors:  Danielle M Moskow; Sarah K Lipson; Martha C Tompson
Journal:  J Am Coll Health       Date:  2022-04-15

5.  Anxiety and its correlates among older adults accessing aging services.

Authors:  Thomas M Richardson; Adam Simning; Hua He; Yeates Conwell
Journal:  Int J Geriatr Psychiatry       Date:  2011-01       Impact factor: 3.485

Review 6.  [Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Authors:  Christine Maria Hörtnagl; Stefan Oberheinricher; Alex Hofer
Journal:  Neuropsychiatr       Date:  2014-06-11

7.  Levels of self-reported depression and anxiety among HIV-positive patients in Albania: a cross-sectional study.

Authors:  Shane D Morrison; Vilson H Banushi; Clea Sarnquist; Valbona H Gashi; Lars Osterberg; Yvonne Maldonado; Arjan Harxhi
Journal:  Croat Med J       Date:  2011-10-15       Impact factor: 1.351

8.  Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression.

Authors:  Benjamin D Schalet; Tony Z Tang; Robert J DeRubeis; Steven D Hollon; Jay D Amsterdam; Richard C Shelton
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

9.  Association of Depression and Anxiety With the Accumulation of Chronic Conditions.

Authors:  William V Bobo; Brandon R Grossardt; Sanya Virani; Jennifer L St Sauver; Cynthia M Boyd; Walter A Rocca
Journal:  JAMA Netw Open       Date:  2022-05-02

10.  Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients.

Authors:  Diego Novick; William Montgomery; Jaume Aguado; Xiaomei Peng; Josep Maria Haro
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-11       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.